CA 19-9 is a tumor marker used in the diagnosis, assessment of patient response to treatment, and monitoring of patients with pancreatic or hepatobiliary cancer. In the diagnosis of pancreatic cancer, the presence of symptoms of pancreatic or biliary obstruction and elevated CA 19-9 will help the physician conclude the risk of pancreatic cancer rather than a benign pancreatic tumor.

CA 19-9 is a tumor marker used in the diagnosis, treatment evaluation, and monitoring of patients with cancer. Quantifying CA 19-9 (carbohydrate antigen 19-9) blood is a special test, supporting the diagnosis of cancer, especially pancreatic cancer.

CA-125 is a cancer marker most commonly used to detect, monitor the effectiveness of ovarian cancer treatment and detect cancer recurrence after treatment. CA-125 testing done repeatedly over time is often more valuable than testing only once.

CA 15-3 cancer antigen is commonly overexpressed in breast cancer cells. Therefore, high CA 15-3 is often used to monitor treatment response and recurrence of breast cancer.

Cancer markers are used to detect, diagnose, and monitor treatment for some cancers. Cancer that is not diagnosed early inevitably leads to death, all current treatment methods (surgery, chemotherapy, radiation therapy...)

Malignant cancer is a disease with rapid proliferation of abnormal cell lines, leading to aggressive invasion and metastasis to surrounding tissues. When performing tests to assess cancer status, elevated levels of cancer markers can cause anxiety in patients undergoing testing.

Cancer has always been one of the leading causes of death in the world. Periodic screening with cancer tests plays an important role in early detection and appropriate treatment orientation. The cancer marker test index is also an effective tool to help increase the definite diagnosis of cancer-positive cases.

Stomach cancer is one of the most common types of cancer today. However, the clinical symptoms of gastric cancer are often vague, poor, and nonspecific. CA 72-4 is one of the important gastric cancer marker tests, very valuable in predicting the risk of gastric cancer.

Tumor markers are substances produced by cancer cells or other cells of the body in response to cancer or certain benign diseases. Most cancer markers are still produced by normal cells, but the amount of these substances is greatly increased in the case of actual cancer. In particular, the cancer marker CA 72-4 is a typical marker for gastric cancer.

CA-125 is an extremely accurate marker for non-mucinous epithelial tumors of the ovary. CA-125 is elevated in more than 80% of women with ovarian cancer. This tumor marker is highly sensitive and specific for ovarian cancer and has been of great help to doctors in making the diagnosis.